Literature DB >> 2533515

The prevalence and patterns of care of Huntington's chorea in Grampian.

S A Simpson1, A W Johnston.   

Abstract

The prevalence of Huntington's chorea in Grampian region is high at 9.94 per 100,000. The 46 individuals (26 female, 20 male) were ascertained from 98 pedigrees. Difficulties in ascertainment, family studies, sex ratio and use of resources are discussed.

Entities:  

Mesh：

Year:  1989        PMID： 2533515     DOI： 10.1192/bjp.155.6.799

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  9 in total

Review 1.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 2.  A systematic review of the incidence and prevalence of long-term neurological conditions in the UK.

Authors:  Thomas Hoppitt; Hardev Pall; Mel Calvert; Paramjit Gill; Guiqing Yao; Jill Ramsay; Gill James; Jacky Conduit; Cath Sackley
Journal:  Neuroepidemiology       Date:  2010-11-17       Impact factor: 3.282

Review 3.  Treatment of Huntington's disease.

Authors:  Samuel Frank
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 4.  The epidemiology of Huntington's disease.

Authors:  P S Harper
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

Review 5.  Advances in the pharmacological management of Huntington's disease.

Authors:  Samuel Frank; Joseph Jankovic
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

6.  Huntington's disease in Grampian region: correlation of the CAG repeat number and the age of onset of the disease.

Authors:  S A Simpson; M J Davidson; L H Barron
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

7.  The epidemiology of Huntington's disease in Northern Ireland.

Authors:  P J Morrison; W P Johnston; N C Nevin
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

8.  Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease.

Authors:  Samuel Frank
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-05       Impact factor: 2.570

9.  The known burden of Huntington disease in the North of Scotland: prevalence of manifest and identified pre-symptomatic gene expansion carriers in the molecular era.

Authors:  Georgios Kounidas; Heather Cruickshank; Stavroula Kastora; Stella Sihlabela; Zosia Miedzybrodzka
Journal:  J Neurol       Date:  2021-04-15       Impact factor: 4.849
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.